Institute for OneWorld Health

From Wikipedia, the free encyclopedia

It has been suggested that The Institute for OneWorld Health be merged into this article or section. (Discuss)

The Institute for OneWorld Health is a nonprofit pharmaceutical company founded in 2000 to develop safe, effective, and affordable new medicines for people with infectious diseases in the developing countries.

Current research involves paromomycin for visceral leishmaniasis. Other research includes developing medications for Chagas disease, schistosomiasis, malaria, and pediatric diarrheal disease.

[edit] External links

http://www.oneworldhealth.org/ website

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.

Retrieved from "http://en.wikipedia.org../../../i/n/s/Institute_for_OneWorld_Health_b6ba.html"

Categories: Articles to be merged since December 2006 | Pharmaceutical companies | Pharmaceutical companies of the United States | Clinical research | Malaria | Medical company stubs

Views

Search